Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01700257 · ClinicalTrials.gov registry record · NA
Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
A NA study, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 1,361
- Enrollment target
NCT01700257 is a NA study that has completed, run by National Jewish Health. The registered enrollment target is 1,361 participants.
The verdict
NCT01700257, a NA study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,361 participants
- Enrollment target
Study Summary
Lung cancer is the number one cancer killer in the USA. Early stage lung cancer is asymptomatic. Most patients with lung cancer are usually symptomatic at diagnosis and already have advanced stage disease. Low dose CT screening (LDCT) for high risk individuals has recently been shown to decrease lung cancer mortality by 20%. However, 4 out of 5 lung cancer deaths are not prevented with LDCT screening alone.
Interventions
- RADIATION CT scan & Early CDT Lung test
- OTHER CT scan & Early CDT Lung test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,361 participants |
| Start Date | 2012-05 |
| Est. Completion | 2020-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01700257
The ClinicalTrials.gov registry entry for NCT01700257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,361 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CT scan & Early CDT Lung test is the first listed.
NCT01700257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01700257 about?
NCT01700257 is a clinical study titled "Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker". Lung cancer is the number one cancer killer in the USA. Early stage lung cancer is asymptomatic. Most patients with lung cancer are usually symptomatic at diagnosis and already have advanced stage disease. Low dose CT screening (LDCT) for high risk individuals has recently been shown to decrease lun...
What is the current status of trial NCT01700257?
This trial is currently completed. It is a NA study. The enrollment target is 1,361 participants. The study started on 2012-05. Estimated completion is 2020-12-07.
What interventions are being tested in trial NCT01700257?
The interventions under investigation include: CT scan & Early CDT Lung test (RADIATION), CT scan & Early CDT Lung test (OTHER).
Who is sponsoring clinical trial NCT01700257?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.